Stock data
Dare Bioscience, Inc. (DARE)
Dare Bioscience, Inc. (DARE) reported revenue of US$1.03M and net income of -US$13.40M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.03M | — | -US$13.55M | -US$13.40M | — |
| 2024 | US$0.01M | — | -US$23.45M | -US$4.05M | — |
| 2023 | US$2.81M | — | -US$30.94M | -US$30.16M | — |
| 2022 | US$10.00M | — | -US$31.39M | -US$30.95M | — |
| 2021 | US$0.00M | — | -US$39.07M | -US$38.70M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.19M | -US$2.98M | — |
| 2026-03-31 | US$0.15M | -US$3.00M | — |
| 2025-12-31 | — | -US$1.44M | — |
| 2025-09-30 | US$0.00M | -US$3.56M | — |
| 2025-06-30 | — | -US$4.02M | — |
| 2025-03-31 | US$0.03M | -US$4.38M | — |
| 2024-12-31 | -US$0.06M | -US$5.51M | — |
| 2024-09-30 | US$0.04M | -US$4.70M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.